• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LUO Gelian,LIN Jinwen,LIN Yongshun,CHEN Chun.Treatment status and economic burden of breast cancer targeted drugs in Fujian Province[J].Journal Of Pharmaceutical Research,2016,35(11):673-676[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3705times   Download 3086次 QR Code for this article
Scan with your phone!
福建省乳腺癌靶向药物治疗现状及其治疗费用分析
罗格莲1,林瑾文1,林永顺2,陈纯3
Font:Larger+|Default|Smaller-
(1.福建生物工程职业技术学院,福建 福州 350002;2.中邮恒泰药业有限公司,福建 福州 350001;3.福建医科大学,福建 福州 350108)
摘要:
目的 探讨福建省乳腺癌靶向药物治疗的现状,分析其治疗费用,为重特大疾病医保政策的制定提供参考依据。方法 调阅福建省九地市医疗保险管理中心信息系统中录入的2012年1月~2014年12月21岁以上参保妇女数据库信息,提取乳腺癌患者资料;至广西、广州、珠海、厦门等地进行实地调研;组织有关部门专家学者以及癌症患者召开座谈会等。结果 近年来,福建省乳腺癌发病率逐年增高,2012~2014年分别为51.70/10万、53.76/10万、54.26/10万; 其中21~40岁妇女发病率升高明显,由2012年的9.13/10万上升至2014年的10.17/10万,呈现年轻化趋势;患者经济负担沉重,尤其联合应用靶向药物治疗费用高达22.7万/人。结论 减轻乳腺癌等大病患者的治疗经济负担关键在于完善重特大疾病医疗保障体系,降低靶向药物治疗费用。
关键词:  乳腺癌  靶向药物  医疗保险
DOI:10.13506/j.cnki.jpr.2016.11.013
基金项目:福建省教育厅项目(No.2015ZX01)
Treatment status and economic burden of breast cancer targeted drugs in Fujian Province
LUO Gelian1,LIN Jinwen1,LIN Yongshun2,CHEN Chun3
(1.Fujian Vocational College of Bioengineering,Fuzhou 350002,China;2.Post Hengtai Pharmaceutical Co.,Ltd.,Fuzhou 350001,China;3.Fujian Medical University,Fuzhou 350108,China)
Abstract:
Objective To explore the current status of breast cancer targeted drug therapy in Fujian Province,and analyze the economic burden of the treatment,so to provide a reference for the establishment of medical insurance policy of major catastrophic disease.Methods Obtaining the breast cancer patients’ data during 2012 to 2014 from informational system of nine cities’ medical insurance management center in Fujian Province;Operating investigation in Guangxi,Guangzhou Zhuhai,Xiamen and other cities;Holding symposium with experts,scholars and cancer patients.Results In recent years,the incidence of breast cancer in Fujian Province increased year by year.The incidences in 2012,2013 and 2014 were 51.70,53.76 and 54.26 per 100 000 people,respectively.The incidence for women who aged from 21 to 40 was particularly increased, from 9.13 per 100 000 in 2012 to 10.17 per 100 000 in 2014.The patients' economic burden was heavy,and the cost of targeted drug therapy reached to ¥227 000 per patient.Conclusion The key to reduce the economic burden of patients with breast cancer and other serious illness is to improve the medical insurance system for major catastrophic disease, and reduce the cost of targeted drugs.
Key words:  Breast cancer  Targeted drugs  Medical insurance
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.